DR. MATTHEW MICHAEL SOCHAT M.D. NPI 1518304849

NPI Information

  • NPI: 1518304849
  • Provider Name: DR. MATTHEW MICHAEL SOCHAT, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 203 COX BLVD
    GOLDSBORO, NC
    ZIP 27534
  • Phone: (199) 580-0000

Map and Directions

Get Directions

NPI Details

DR. Matthew Michael Sochat, M.D. is a hematology and oncology internal medicine in Goldsboro, NC with 13 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Matthew Michael Sochat, M.D. NPI is 1518304849. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: WARREN ALPERT MEDICAL SCHOOL OF BROWN UNIVERSITY
Graduation Year:2013

The provider's business location address is:

203 COX BLVD
GOLDSBORO, NC
ZIP 27534-479
Phone: (199) 580-0000

The NPI 1518304849 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, tildrakizumab, 1 mg (HCPCS:J3245)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron binding capacity (HCPCS:83550)
  • Iron level (HCPCS:83540)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Magnesium level (HCPCS:83735)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 5/28/2013 and was last updated on 3/18/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine2020-00287NORTH CAROLINANo
2207RH0003XInternal MedicineHematology & Oncology2020-00287NORTH CAROLINAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.